| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.68e-05 | 18 | 200 | 4 | GO:0008569 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.08e-05 | 14 | 196 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.08e-05 | 14 | 196 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.08e-05 | 14 | 196 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.08e-05 | 14 | 196 | 4 | PF08393 | |
| Domain | MT | 1.08e-05 | 14 | 196 | 4 | PF12777 | |
| Domain | AAA_8 | 1.08e-05 | 14 | 196 | 4 | PF12780 | |
| Domain | DHC_fam | 1.47e-05 | 15 | 196 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.47e-05 | 15 | 196 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.47e-05 | 15 | 196 | 4 | IPR004273 | |
| Domain | TB2_DP1_HVA22 | 2.22e-05 | 6 | 196 | 3 | IPR004345 | |
| Domain | TB2_DP1_HVA22 | 2.22e-05 | 6 | 196 | 3 | PF03134 | |
| Domain | DHC_N1 | 6.13e-05 | 8 | 196 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 6.13e-05 | 8 | 196 | 3 | IPR013594 | |
| Domain | ATP_grasp_subdomain_2 | 2.96e-04 | 31 | 196 | 4 | IPR013816 | |
| Domain | Rhs_assc_core | 3.26e-04 | 3 | 196 | 2 | IPR022385 | |
| Domain | PI3K_P85_iSH2 | 3.26e-04 | 3 | 196 | 2 | IPR032498 | |
| Domain | UPF0560 | 3.26e-04 | 3 | 196 | 2 | PF10577 | |
| Domain | Uncharacterised_FAM171 | 3.26e-04 | 3 | 196 | 2 | IPR018890 | |
| Domain | PI3K_P85_iSH2 | 3.26e-04 | 3 | 196 | 2 | PF16454 | |
| Domain | ATPase_dyneun-rel_AAA | 3.80e-04 | 14 | 196 | 3 | IPR011704 | |
| Domain | AAA_5 | 3.80e-04 | 14 | 196 | 3 | PF07728 | |
| Domain | Tox-GHH_dom | 6.48e-04 | 4 | 196 | 2 | IPR028916 | |
| Domain | Tox-GHH | 6.48e-04 | 4 | 196 | 2 | PF15636 | |
| Domain | DNA_mmatch_repair_MutS_con_dom | 6.48e-04 | 4 | 196 | 2 | IPR007860 | |
| Domain | Hox9_activation_N | 6.48e-04 | 4 | 196 | 2 | IPR006711 | |
| Domain | MutS_II | 6.48e-04 | 4 | 196 | 2 | PF05188 | |
| Domain | Ten_N | 6.48e-04 | 4 | 196 | 2 | IPR009471 | |
| Domain | Ten_N | 6.48e-04 | 4 | 196 | 2 | PF06484 | |
| Domain | HXA9/HXB9/HXC9 | 6.48e-04 | 4 | 196 | 2 | IPR017112 | |
| Domain | TENEURIN_N | 6.48e-04 | 4 | 196 | 2 | PS51361 | |
| Domain | Hox9_act | 6.48e-04 | 4 | 196 | 2 | PF04617 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 8.27e-04 | 18 | 196 | 3 | IPR008930 | |
| Domain | MUTSd | 1.07e-03 | 5 | 196 | 2 | SM00533 | |
| Domain | MUTSac | 1.07e-03 | 5 | 196 | 2 | SM00534 | |
| Domain | PHR | 1.07e-03 | 5 | 196 | 2 | IPR012983 | |
| Domain | MutS_V | 1.07e-03 | 5 | 196 | 2 | PF00488 | |
| Domain | FGGY_KINASES_1 | 1.07e-03 | 5 | 196 | 2 | PS00933 | |
| Domain | YD | 1.07e-03 | 5 | 196 | 2 | IPR006530 | |
| Domain | DNA_mismatch_repair_MutS_clamp | 1.07e-03 | 5 | 196 | 2 | IPR007861 | |
| Domain | DNA_MISMATCH_REPAIR_2 | 1.07e-03 | 5 | 196 | 2 | PS00486 | |
| Domain | PHR | 1.07e-03 | 5 | 196 | 2 | PF08005 | |
| Domain | MutS_IV | 1.07e-03 | 5 | 196 | 2 | PF05190 | |
| Domain | MutS_III | 1.07e-03 | 5 | 196 | 2 | PF05192 | |
| Domain | FGGY_KINASES_2 | 1.07e-03 | 5 | 196 | 2 | PS00445 | |
| Domain | DNA_mismatch_repair_MutS_C | 1.07e-03 | 5 | 196 | 2 | IPR000432 | |
| Domain | PI3kinase_P85 | 1.07e-03 | 5 | 196 | 2 | IPR001720 | |
| Domain | CPSASE_1 | 1.07e-03 | 5 | 196 | 2 | PS00866 | |
| Domain | DNA_mismatch_repair_MutS_core | 1.07e-03 | 5 | 196 | 2 | IPR007696 | |
| Domain | Carb_kinase_FGGY_N | 1.60e-03 | 6 | 196 | 2 | IPR018484 | |
| Domain | DUF3398 | 1.60e-03 | 6 | 196 | 2 | PF11878 | |
| Domain | CPSASE_2 | 1.60e-03 | 6 | 196 | 2 | PS00867 | |
| Domain | DOCK_C/D_N | 1.60e-03 | 6 | 196 | 2 | IPR021816 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TANC2 CLUAP1 DCTN5 MCM4 CLASP2 NCAPG2 RCOR1 MRPS17 PI4KB EIF2B3 PTPRQ ZBTB21 PAN2 KIF13B RB1 DYNC2H1 RADX CIP2A VPS50 ATG2B MED1 REEP3 LRPPRC THADA PIGT TRAPPC10 IFT122 REEP4 | 4.08e-09 | 1321 | 203 | 28 | 27173435 |
| Pubmed | DDX47 ATP7A MAN2A1 MCM4 CLASP2 NCAPG2 ATP8A1 PIGA CD302 ZDHHC13 FLNA DOCK9 ANXA6 VPS50 DOCK10 MED1 CPT1A PARP14 LRPPRC PIGT PLXNC1 CHD5 EIF4G2 IFT122 ENO1 | 2.48e-08 | 1168 | 203 | 25 | 19946888 | |
| Pubmed | DDX47 TANC2 RCOR1 MTA3 SGPL1 PIK3R2 GRAP2 ZBTB21 ZDHHC13 USP36 RB1 PIK3R3 VPS50 BUD13 PARS2 LGALS3BP MSH6 INTS6 THADA MORF4L2 CHD5 CRYBG3 PHF10 | 1.83e-07 | 1116 | 203 | 23 | 31753913 | |
| Pubmed | 2.30e-07 | 10 | 203 | 4 | 38713721 | ||
| Pubmed | 1.08e-06 | 14 | 203 | 4 | 9373155 | ||
| Pubmed | DCTN5 MCM4 EFHB MTA3 AP1B1 RBM27 MRPS17 FLNA RADX DOCK9 MRPL58 BUD13 MED1 DNAH7 LRPPRC NSUN3 MRPL15 MORF4L2 TTLL2 CHD5 ENO1 PHF10 | 1.24e-06 | 1153 | 203 | 22 | 29845934 | |
| Pubmed | PLBD1 TMEM241 TRMT11 ITFG1 CC2D2B PTPRZ1 SHOC1 PAN2 XRRA1 AMPD3 SLC25A21 VPS50 MSH4 REEP3 CDC14A HYDIN | 3.17e-06 | 686 | 203 | 16 | 29987050 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 TEX2 CLASP2 SGPL1 A2ML1 PZP NPTX2 MAGI3 UFL1 INTS6 CTSD ENO1 PHF10 | 5.03e-06 | 475 | 203 | 13 | 31040226 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX47 SACS RBM27 PAN2 PZP VRK1 NPTX2 SYNE1 ANXA6 BUD13 PRPF38B UFL1 MED1 PARS2 MSH6 INTS6 LRPPRC MORF4L2 MKX CSTF1 | 6.20e-06 | 1082 | 203 | 20 | 38697112 |
| Pubmed | ATP7A TEX2 CLASP2 DNAJB9 NCAPG2 SACS MRPS17 PIK3R2 DYNC2H1 SYNE1 CIP2A PIK3R3 MRPL58 UFL1 DEGS1 LGALS3BP LRPPRC THADA MRPL15 FAM171A2 EIF4G2 IFT122 CRYBG3 REEP4 | 7.05e-06 | 1487 | 203 | 24 | 33957083 | |
| Pubmed | 9.98e-06 | 49 | 203 | 5 | 21362503 | ||
| Pubmed | CLASP2 DNAJB9 NCAPG2 SGPL1 PIK3R2 NPAP1 STRA6 FLNA VRK1 ICE2 COP1 PRPF38B UFL1 ERI1 MED1 CCNA2 USP14 MSH6 INTS6 ERG28 REEP4 PHF10 | 1.16e-05 | 1327 | 203 | 22 | 32694731 | |
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 1.29e-05 | 25 | 203 | 4 | 8889551 | |
| Pubmed | DDX47 NCAPG2 MRPS17 SGPL1 EIF2B3 FLNA CIP2A ANXA6 PGAP4 UFL1 LGALS3BP CCNA2 USP14 MSH6 LRPPRC THADA PIGT MRPL15 EIF4G2 MKX TRAPPC10 TMOD1 ENO1 | 1.31e-05 | 1440 | 203 | 23 | 30833792 | |
| Pubmed | 1.34e-05 | 52 | 203 | 5 | 26499835 | ||
| Pubmed | RTP family members induce functional expression of mammalian odorant receptors. | 2.28e-05 | 10 | 203 | 3 | 15550249 | |
| Pubmed | Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. | 2.28e-05 | 10 | 203 | 3 | 16271481 | |
| Pubmed | 2.50e-05 | 59 | 203 | 5 | 31551363 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX47 TRMT11 MCM4 CLASP2 TSNAX BTBD1 PAN2 USP36 KIF13B FLNA DYNC2H1 MAGI3 PRPF38B CCNA2 USP14 LRPPRC EIF4G2 CSTF1 | 2.78e-05 | 1005 | 203 | 18 | 19615732 |
| Pubmed | MCM4 TSNAX RCOR1 MTA3 AP1B1 SGPL1 EIF2B3 VPS50 MSH6 INTS6 LRPPRC PIGT EIF4G2 | 2.85e-05 | 560 | 203 | 13 | 35241646 | |
| Pubmed | RIMS3 TENM2 PLEKHH1 HERC3 ADGRL3 SYNE1 DOCK9 DOCK10 PUM2 TENM3 CIPC | 3.04e-05 | 407 | 203 | 11 | 12693553 | |
| Pubmed | 3.28e-05 | 103 | 203 | 6 | 10574462 | ||
| Pubmed | Evidence for multiple, developmentally regulated isoforms of Ptprq on hair cells of the inner ear. | 3.39e-05 | 2 | 203 | 2 | 20715155 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 1840592 | ||
| Pubmed | The PPARgamma2 A/B-domain plays a gene-specific role in transactivation and cofactor recruitment. | 3.39e-05 | 2 | 203 | 2 | 19282365 | |
| Pubmed | Glioblastoma cancer stem cells--from concept to clinical application. | 3.39e-05 | 2 | 203 | 2 | 22668828 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 2578455 | ||
| Pubmed | Teneurin-3 controls topographic circuit assembly in the hippocampus. | 3.39e-05 | 2 | 203 | 2 | 29414938 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 12920182 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 30814992 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 11598000 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 25739457 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 23911198 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 7528167 | ||
| Pubmed | Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. | 3.39e-05 | 2 | 203 | 2 | 10676968 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24129546 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 26647854 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 26130665 | ||
| Pubmed | Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. | 3.39e-05 | 2 | 203 | 2 | 17123335 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 21632707 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 25332192 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 21666065 | ||
| Pubmed | Enhancing adult nerve regeneration through the knockdown of retinoblastoma protein. | 3.39e-05 | 2 | 203 | 2 | 24752312 | |
| Pubmed | REEP3 and REEP4 determine the tubular morphology of the endoplasmic reticulum during mitosis. | 3.39e-05 | 2 | 203 | 2 | 30995177 | |
| Pubmed | Structural mechanism underlying ligand binding and activation of PPARγ. | 3.39e-05 | 2 | 203 | 2 | 33713599 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 26599207 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 26452216 | ||
| Pubmed | TANC2 LAPTM5 SACS SGPL1 KIF13B SH3TC2 DYNC2H1 CIP2A MAGI3 THADA DIP2C UBR3 | 3.68e-05 | 493 | 203 | 12 | 15368895 | |
| Pubmed | MAN2A1 DCTN5 CLASP2 MTA3 RBM27 MRPS17 SGPL1 USP36 SYNE1 PUM2 BUD13 PRPF38B UFL1 MED1 RIOX2 MSH6 INTS6 PIGT MORF4L2 EIF4G2 CSTF1 REEP4 | 7.04e-05 | 1497 | 203 | 22 | 31527615 | |
| Pubmed | TEX2 ETS1 CLASP2 TSNAX RCOR1 SGPL1 PAN2 KIF13B FLNA DOCK9 FAM171B MTMR6 EIF4G2 MKX TRAPPC10 CIPC FUCA2 DOT1L | 7.34e-05 | 1084 | 203 | 18 | 11544199 | |
| Pubmed | 8.63e-05 | 177 | 203 | 7 | 26206133 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAN2A1 NCAPG2 ITFG1 FANCA SGPL1 ZDHHC13 PGAP4 CPT1A DEGS1 LGALS3BP TGFB2 SLC6A6 THADA PIGT ERG28 TENM3 RIMOC1 FUCA2 CTSD | 8.72e-05 | 1201 | 203 | 19 | 35696571 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TANC2 ATP7A ITFG1 FANCA AP1B1 SGPL1 ZDHHC13 SYNE1 CIP2A MAGI3 PGAP4 INTS6 THADA TENM3 | 9.32e-05 | 719 | 203 | 14 | 35337019 |
| Pubmed | MTA3 SGPL1 PIK3R2 RB1 CIP2A PIK3R3 IDH1 CCNA2 MSH6 LRPPRC CSTF1 ENO1 PHF10 | 9.99e-05 | 634 | 203 | 13 | 34591612 | |
| Pubmed | Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ. | 1.01e-04 | 3 | 203 | 2 | 30575522 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 9219533 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 7513640 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 30611282 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 35230372 | ||
| Pubmed | PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner. | 1.01e-04 | 3 | 203 | 2 | 12833141 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 25352638 | ||
| Pubmed | Interaction between human cyclin A and adenovirus E1A-associated p107 protein. | 1.01e-04 | 3 | 203 | 2 | 1532458 | |
| Pubmed | 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization. | 1.01e-04 | 3 | 203 | 2 | 15828833 | |
| Pubmed | DOT1L promotes angiogenesis through cooperative regulation of VEGFR2 with ETS-1. | 1.01e-04 | 3 | 203 | 2 | 27626484 | |
| Pubmed | alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. | 1.01e-04 | 3 | 203 | 2 | 10487856 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 12588990 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 20530198 | ||
| Pubmed | Roles of the DOCK-D family proteins in a mouse model of neuroinflammation. | 1.01e-04 | 3 | 203 | 2 | 32241915 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 22647598 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 29519872 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 21445343 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 10037764 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 12183561 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 23117818 | ||
| Pubmed | Alpha-2 macroglobulin controls trophoblast positioning in mouse implantation sites. | 1.01e-04 | 3 | 203 | 2 | 14580373 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 9708794 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 8830800 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 8662763 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 36857183 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 18039840 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 25262148 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 26851024 | ||
| Pubmed | ACACB ETS1 RCOR1 HOXB9 MTA3 RBM27 MRPS17 ZBTB21 RB1 RADX COP1 PUM2 PPARG LGALS3BP CCNA2 MRPL15 MORF4L2 CHD5 CSTF1 DOT1L PHF10 | 1.04e-04 | 1429 | 203 | 21 | 35140242 | |
| Pubmed | 1.09e-04 | 247 | 203 | 8 | 30713523 | ||
| Pubmed | REEP1 TEX2 CLASP2 SGPL1 RADX ICE2 CIP2A VPS50 PUM2 REEP3 SLC6A6 USP14 MTMR6 REEP4 | 1.14e-04 | 733 | 203 | 14 | 34672954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACB MCM4 TSNAX RBM27 ZBTB21 USP36 FLNA ATG2B PUM2 PRPF38B IDH1 MED1 USP14 MSH6 EIF4G2 ENO1 | 1.31e-04 | 934 | 203 | 16 | 33916271 |
| Pubmed | TANC2 REEP1 ACACB TEX2 TENM2 ADGRL3 FLNA DOCK9 ATG2B PRPF38B FAM171B LRPPRC FAM171A2 SNX25 EIF4G2 UBR3 CRYBG3 ENO1 | 1.36e-04 | 1139 | 203 | 18 | 36417873 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.40e-04 | 256 | 203 | 8 | 24189400 | |
| Pubmed | WBP2 DCTN5 MCM4 CLASP2 RCOR1 HOXB9 PIK3R2 FLNA BUD13 PRPF38B IDH1 MED1 TGFB2 USP14 LRPPRC EIF4G2 TRAPPC10 DOT1L ENO1 | 1.42e-04 | 1247 | 203 | 19 | 27684187 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | BTBD1 NCAPG2 FANCA AP1B1 EIF2B3 FLNA DYNC2H1 CIP2A DNAH2 UFL1 CPT1A USP14 LRPPRC THADA FAM171A2 EIF4G2 | 1.44e-04 | 942 | 203 | 16 | 31073040 |
| Pubmed | 1.50e-04 | 18 | 203 | 3 | 9090377 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ETS1 MCM4 CDKL1 HOXB9 A2ML1 ZBTB21 VRK1 RB1 COP1 UFL1 PPARG CPS1 PARS2 LGALS3BP MORF4L2 | 1.69e-04 | 857 | 203 | 15 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 TEX2 CLASP2 RRM2 PI4KB ZBTB21 KIF13B MAGI3 REEP3 DNAH7 CDC14A LRPPRC FAM171A2 CRYBG3 REEP4 | 1.78e-04 | 861 | 203 | 15 | 36931259 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | ACACB XRRA1 MTMR8 DOCK10 DNAH7 CDC14A MTMR6 EIF4G2 REEP4 CTSD | 1.97e-04 | 420 | 203 | 10 | 28065597 |
| Pubmed | WBP2 ATP7A ACACB PIK3R2 PIK3R3 UFL1 FAM171B LRPPRC FAM171A2 TENM3 | 2.00e-04 | 421 | 203 | 10 | 36976175 | |
| Pubmed | ATP7A TEX2 SGPL1 PIK3R2 PI4KB ZDHHC13 ATG2B HPS3 PIGT RIMOC1 REEP4 | 2.01e-04 | 504 | 203 | 11 | 34432599 | |
| Pubmed | 2.02e-04 | 4 | 203 | 2 | 7524394 | ||
| Pubmed | 2.02e-04 | 4 | 203 | 2 | 27031383 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 2.02e-04 | 4 | 203 | 2 | 10225957 | |
| Pubmed | 2.02e-04 | 4 | 203 | 2 | 27612006 | ||
| Cytoband | 2p21 | 1.59e-04 | 61 | 203 | 4 | 2p21 | |
| GeneFamily | Receptor accessory proteins | 8.19e-06 | 6 | 136 | 3 | 717 | |
| GeneFamily | Dyneins, axonemal | 2.62e-04 | 17 | 136 | 3 | 536 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 3.34e-04 | 4 | 136 | 2 | 833 | |
| GeneFamily | MutS homologs|PWWP domain containing | 5.53e-04 | 5 | 136 | 2 | 1026 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.95e-03 | 9 | 136 | 2 | 1234 | |
| GeneFamily | Chloride voltage-gated channels | 2.43e-03 | 10 | 136 | 2 | 302 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.44e-03 | 134 | 136 | 5 | 861 | |
| GeneFamily | PHD finger proteins|NuRD complex | 3.53e-03 | 12 | 136 | 2 | 1305 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | TANC2 REEP1 MBOAT1 TEX2 CLASP2 HOXD9 OLFML1 ICE2 SYNE1 DTX3 PGAP4 CCNJ PPARG FAM171B CPT1A SLC6A6 SNX25 IFT122 | 1.24e-06 | 604 | 203 | 18 | M45760 |
| Coexpression | GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN | RRM2 NCAPG2 FANCA PROM1 HERC3 NPR2 DTX3 CIP2A PIK3R3 LGALS3BP | 3.73e-06 | 199 | 203 | 10 | M5983 |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | MAN2A1 CLASP2 NCAPG2 MTA3 AP1B1 PAN2 PARS2 CCNA2 PLXNC1 CRYBG3 | 3.90e-06 | 200 | 203 | 10 | M8048 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 | CLUAP1 REEP1 GBP1 KLHL41 EFHB ZBTB21 DENND6B DNAH5 NPTX2 CFAP43 DNAH7 TTLL6 MKX CIPC PHF10 | 4.46e-06 | 471 | 203 | 15 | M3062 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | CLUAP1 GBP1 EFHB CDKL1 PROM1 SGPL1 DENND6B XRRA1 PZP DNAH5 AMPD3 DYNC2H1 SYNE1 DTX3 DNAH2 CFAP43 DNAH7 CDC14A THADA PIGT MORF4L2 CIPC IFT122 HYDIN | 4.51e-06 | 1093 | 203 | 24 | M41649 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TANC2 MGAT4A CLASP2 BTBD1 DNAJB9 ATP8A1 PIGA PAN2 DNAH5 UNC79 NPR2 NPTX2 DTX3 DOCK10 PIR SLC6A6 LRPPRC MTMR6 DIP2C TMOD1 ENO1 | 1.58e-05 | 946 | 203 | 21 | M39169 |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 1.81e-05 | 145 | 203 | 8 | M3045 | |
| Coexpression | LE_EGR2_TARGETS_UP | 2.30e-05 | 109 | 203 | 7 | MM1148 | |
| Coexpression | LE_EGR2_TARGETS_UP | 2.44e-05 | 110 | 203 | 7 | M12804 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP | 2.76e-05 | 200 | 203 | 9 | M9336 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | MAN2A1 MGAT4A TRMT11 GBP1 TSNAX DNAJB9 RRM2 ATP8A1 SACS ZBTB21 ICE2 DOCK10 UFL1 RIOX2 LRPPRC UBR3 PHF10 | 2.76e-05 | 687 | 203 | 17 | M41022 |
| Coexpression | BENPORATH_ES_1 | MAN2A1 ZGRF1 MCM4 RRM2 NCAPG2 PROM1 MTA3 PTPRZ1 ICE2 HPS3 CCNA2 MSH6 | 4.35e-05 | 379 | 203 | 12 | M1871 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | TMEM241 DCTN5 MCM4 RRM2 FANCA PAN2 VRK1 ICE2 CIP2A CFAP43 ERI1 PARS2 CCNA2 MSH6 ERG28 RIMOC1 CSTF1 | 4.47e-05 | 714 | 203 | 17 | M1744 |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 6.41e-05 | 88 | 203 | 6 | M5360 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 1.38e-04 | 101 | 203 | 6 | M15356 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | ZGRF1 MCM4 CLASP2 RRM2 FANCA SGPL1 PAN2 ZDHHC13 USP36 ICE2 DNAH2 PPARG CPS1 FAM171B REEP3 CCNA2 MTMR6 THADA TRAPPC10 REEP4 | 1.45e-04 | 1023 | 203 | 20 | M17122 |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP | 1.47e-04 | 195 | 203 | 8 | M10001 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN | 1.52e-04 | 196 | 203 | 8 | M6160 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP | 1.69e-04 | 199 | 203 | 8 | M9759 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN | 1.69e-04 | 199 | 203 | 8 | M4055 | |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.75e-04 | 200 | 203 | 8 | M9392 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN | 1.75e-04 | 200 | 203 | 8 | M386 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN | 1.75e-04 | 200 | 203 | 8 | M9928 | |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 1.75e-04 | 200 | 203 | 8 | M7981 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_UP | 1.75e-04 | 200 | 203 | 8 | M5461 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_DC_DN | 1.75e-04 | 200 | 203 | 8 | M4476 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | REEP1 PLEKHH1 PROM1 SELENOV PTPRZ1 RB1 DYNC2H1 PIK3R3 CCNJ FAM171B REEP3 SLCO5A1 PLXNC1 EIF4G2 | 2.44e-05 | 395 | 200 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 3.10e-05 | 129 | 200 | 8 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_200 | GBP1 DYSF C16orf89 ATP8A1 SYNE1 PPARG PARP14 CDC14A LGALS3BP | 3.81e-05 | 172 | 200 | 9 | gudmap_kidney_adult_RenMedVasc_Tie2_200 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | REEP1 TENM2 PLEKHH1 PROM1 PTPRZ1 RB1 IDH1 REEP3 CDC14A PLXNC1 | 5.69e-05 | 225 | 200 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | REEP1 EFHB PROM1 DENND6B PZP DNAH5 DYNC2H1 DNAH2 CFAP43 DNAH7 HYDIN | 7.29e-10 | 180 | 203 | 11 | 92fb01b91261b3103454924cde56add337b41844 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CLUAP1 EFHB PROM1 SHOC1 DNAH5 DYNC2H1 SYNE1 DNAH2 CFAP43 DNAH7 HYDIN | 1.61e-09 | 194 | 203 | 11 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CLUAP1 EFHB PROM1 PZP DNAH5 DYNC2H1 DNAH2 CFAP43 DNAH7 HYDIN | 6.00e-09 | 169 | 203 | 10 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MCM4 RRM2 EFHB DNAH5 SLC25A21 DNAH2 CFAP43 INTS6 TENM3 HYDIN | 9.87e-09 | 178 | 203 | 10 | 6178706db4a855d72abc156537604d575624df56 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MCM4 RRM2 EFHB DNAH5 SLC25A21 DNAH2 CFAP43 INTS6 TENM3 HYDIN | 9.87e-09 | 178 | 203 | 10 | f02076ece0fa899e620971c887ad4da7f48684ed |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CDKL1 NPAP1 DNAH5 DYNC2H1 SYNE1 DNAH2 CFAP43 DNAH7 TTLL6 HYDIN | 2.59e-08 | 197 | 203 | 10 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-07 | 173 | 203 | 9 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 189 | 203 | 9 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.69e-07 | 193 | 203 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-07 | 193 | 203 | 9 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.81e-07 | 194 | 203 | 9 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.93e-07 | 195 | 203 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.20e-07 | 197 | 203 | 9 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-07 | 197 | 203 | 9 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-07 | 197 | 203 | 9 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-07 | 197 | 203 | 9 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-07 | 197 | 203 | 9 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.33e-07 | 198 | 203 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 199 | 203 | 9 | e1190b1c2d21fed313bb58e24d0e6365de6e6599 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.63e-07 | 200 | 203 | 9 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.63e-07 | 200 | 203 | 9 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 3.63e-07 | 200 | 203 | 9 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.83e-07 | 155 | 203 | 8 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.83e-07 | 155 | 203 | 8 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-06 | 168 | 203 | 8 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 1.07e-06 | 168 | 203 | 8 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 175 | 203 | 8 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 180 | 203 | 8 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.88e-06 | 181 | 203 | 8 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 1.88e-06 | 181 | 203 | 8 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 1.88e-06 | 181 | 203 | 8 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 183 | 203 | 8 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-06 | 185 | 203 | 8 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.21e-06 | 185 | 203 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-06 | 185 | 203 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-06 | 187 | 203 | 8 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 190 | 203 | 8 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-06 | 191 | 203 | 8 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.91e-06 | 192 | 203 | 8 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-06 | 193 | 203 | 8 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.14e-06 | 194 | 203 | 8 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.14e-06 | 194 | 203 | 8 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-06 | 195 | 203 | 8 | 0fbba312e9ba9b70b4b814b67b6eb1f6544aaf6d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-06 | 195 | 203 | 8 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-06 | 195 | 203 | 8 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-06 | 195 | 203 | 8 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 3.39e-06 | 196 | 203 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.39e-06 | 196 | 203 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-06 | 196 | 203 | 8 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-06 | 196 | 203 | 8 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.39e-06 | 196 | 203 | 8 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.52e-06 | 197 | 203 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-06 | 197 | 203 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.52e-06 | 197 | 203 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_Tem|Bac-SEP / Disease, condition lineage and cell class | 3.65e-06 | 198 | 203 | 8 | 292b26f316f016b50d07689f84772eec46060251 | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.79e-06 | 199 | 203 | 8 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-06 | 199 | 203 | 8 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.79e-06 | 199 | 203 | 8 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.79e-06 | 199 | 203 | 8 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.79e-06 | 199 | 203 | 8 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | Severe-Lymphoid-T-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 3.93e-06 | 200 | 203 | 8 | 266270c756fb69945449ce02da04743cd31f8158 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.93e-06 | 200 | 203 | 8 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.93e-06 | 200 | 203 | 8 | 195862a319794e57f0506757ae45ab70200bc5b4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 200 | 203 | 8 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 200 | 203 | 8 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 200 | 203 | 8 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 200 | 203 | 8 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-06 | 200 | 203 | 8 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 200 | 203 | 8 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 200 | 203 | 8 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 154 | 203 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 154 | 203 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.30e-06 | 161 | 203 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 165 | 203 | 7 | 479962ce1c3d6636ae62b6709635299748653801 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 167 | 203 | 7 | e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 167 | 203 | 7 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 167 | 203 | 7 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-05 | 168 | 203 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 168 | 203 | 7 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 168 | 203 | 7 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 168 | 203 | 7 | 2c996d09b6a8ccd3c708146eca310b02eafff425 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-05 | 169 | 203 | 7 | 3e40ae0b23a962e0f15908872dec63f51c5b8b83 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-05 | 169 | 203 | 7 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 173 | 203 | 7 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.48e-05 | 173 | 203 | 7 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 175 | 203 | 7 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 175 | 203 | 7 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 176 | 203 | 7 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 177 | 203 | 7 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 177 | 203 | 7 | 7853430fb0d1a18d835e8956777e0616c5d7d412 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 177 | 203 | 7 | 9a5bf67a801826d094f679dd2189b62296c9694f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 177 | 203 | 7 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-05 | 177 | 203 | 7 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 177 | 203 | 7 | 395f005f019aabb18738d3a10a04c37f216deda3 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 177 | 203 | 7 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-05 | 178 | 203 | 7 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 178 | 203 | 7 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 178 | 203 | 7 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 178 | 203 | 7 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 179 | 203 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| Disease | hereditary spastic paraplegia 31 (implicated_via_orthology) | 5.86e-06 | 6 | 198 | 3 | DOID:0110782 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | RRM2 ZNF804A PROM1 HOXD9 SACS NPAP1 PAN2 PZP SYNE1 IDH1 PPARG CDC14A HPS3 MSH6 CHD5 DIP2C | 2.32e-05 | 702 | 198 | 16 | C0009402 |
| Disease | human papilloma virus infection, oropharynx cancer | 2.86e-05 | 53 | 198 | 5 | EFO_0001668, EFO_1001931 | |
| Disease | serum metabolite measurement, glycine measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0005653, EFO_0009767 | |
| Disease | 5-hydroxymethyl-2-furoylcarnitine measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0801053 | |
| Disease | X-24757 measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0800905 | |
| Disease | Cold paroxysmal hemoglobinuria | 4.48e-05 | 2 | 198 | 2 | C0086774 | |
| Disease | cinnamoylglycine measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0800962 | |
| Disease | Hemoglobinuria, Paroxysmal | 4.48e-05 | 2 | 198 | 2 | C0019050 | |
| Disease | isovalerylglycine measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0800025 | |
| Disease | N-acetylaspartic acid measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0801183 | |
| Disease | serum metabolite measurement, creatine measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0005653, EFO_0010472 | |
| Disease | NMMA measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0801206 | |
| Disease | X-17367 measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0800779 | |
| Disease | butyrylglycine measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0800208 | |
| Disease | monocyte chemotactic protein 3 measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0008235 | |
| Disease | X-08988 measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0021207 | |
| Disease | X-25420 measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0800926 | |
| Disease | indolepropionylglycine measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0800089 | |
| Disease | 2-methylserine measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0800087 | |
| Disease | tigloylglycine measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0800121 | |
| Disease | Paroxysmal nocturnal hemoglobinuria | 1.34e-04 | 3 | 198 | 2 | C0024790 | |
| Disease | glycine measurement, amino acid measurement | 2.66e-04 | 4 | 198 | 2 | EFO_0005134, EFO_0009767 | |
| Disease | gamma-glutamylcitrulline measurement | 2.66e-04 | 4 | 198 | 2 | EFO_0800690 | |
| Disease | Multiple congenital anomalies-hypotonia-seizures syndrome | 2.66e-04 | 4 | 198 | 2 | cv:C5191419 | |
| Disease | amino acid measurement, citrulline measurement | 2.66e-04 | 4 | 198 | 2 | EFO_0005134, EFO_0009777 | |
| Disease | pirin measurement | 2.66e-04 | 4 | 198 | 2 | EFO_0801884 | |
| Disease | urinary sodium to creatinine ratio | 2.66e-04 | 4 | 198 | 2 | EFO_0009883 | |
| Disease | isobutyrylglycine measurement | 2.66e-04 | 4 | 198 | 2 | EFO_0800029 | |
| Disease | X-17325 measurement | 2.66e-04 | 4 | 198 | 2 | EFO_0800771 | |
| Disease | urate measurement, bone density | MBOAT1 ETS1 CLASP2 TENM2 FANCA A2ML1 CD302 SYNE1 UGT1A6 MAGI3 USP14 PLXNC1 EIF4G2 | 3.03e-04 | 619 | 198 | 13 | EFO_0003923, EFO_0004531 |
| Disease | cholelithiasis | 3.23e-04 | 88 | 198 | 5 | EFO_0004799 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.38e-04 | 144 | 198 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | propionylglycine measurement | 4.42e-04 | 5 | 198 | 2 | EFO_0800207 | |
| Disease | 2-butenoylglycine measurement | 4.42e-04 | 5 | 198 | 2 | EFO_0800556 | |
| Disease | 3-hydroxybutyroylglycine measurement | 4.42e-04 | 5 | 198 | 2 | EFO_0800568 | |
| Disease | lysine measurement, amino acid measurement | 4.42e-04 | 5 | 198 | 2 | EFO_0005002, EFO_0005134 | |
| Disease | L-arginine measurement, amino acid measurement | 4.42e-04 | 5 | 198 | 2 | EFO_0005134, EFO_0006524 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 5.43e-04 | 24 | 198 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | Neurologic Deficits | 6.60e-04 | 6 | 198 | 2 | C0521654 | |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 6.60e-04 | 6 | 198 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | 3-methylglutaconate measurement | 6.60e-04 | 6 | 198 | 2 | EFO_0800047 | |
| Disease | 5-methylthioadenosine (MTA) measurement | 6.60e-04 | 6 | 198 | 2 | EFO_0800130 | |
| Disease | 2,3-dihydroxy-5-methylthio-4-pentenoate (DMTPA) measurement | 6.60e-04 | 6 | 198 | 2 | EFO_0800111 | |
| Disease | urinary potassium to creatinine ratio | 6.60e-04 | 6 | 198 | 2 | EFO_0009882 | |
| Disease | X-16570 measurement | 6.60e-04 | 6 | 198 | 2 | EFO_0800759 | |
| Disease | macular telangiectasia type 2 | 6.90e-04 | 26 | 198 | 3 | EFO_1002009 | |
| Disease | ergothioneine measurement | 6.90e-04 | 26 | 198 | 3 | EFO_0021163 | |
| Disease | stimulant use measurement | 8.61e-04 | 28 | 198 | 3 | EFO_0600076 | |
| Disease | embryonal carcinoma (is_marker_for) | 9.20e-04 | 7 | 198 | 2 | DOID:3308 (is_marker_for) | |
| Disease | hexanoylglycine measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0800233 | |
| Disease | Cerebral ventriculomegaly | 9.20e-04 | 7 | 198 | 2 | C1531647 | |
| Disease | gamma-glutamylglycine measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0800670 | |
| Disease | Hydrocephalus Ex-Vacuo | 9.20e-04 | 7 | 198 | 2 | C0270720 | |
| Disease | amino acid measurement, threonine measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0005134, EFO_0009775 | |
| Disease | Communicating Hydrocephalus | 9.20e-04 | 7 | 198 | 2 | C0009451 | |
| Disease | neuronal pentraxin-2 measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0801834 | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 9.20e-04 | 7 | 198 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | Fetal Cerebral Ventriculomegaly | 9.20e-04 | 7 | 198 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 9.20e-04 | 7 | 198 | 2 | C0477432 | |
| Disease | N-palmitoylglycine measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0800342 | |
| Disease | Obstructive Hydrocephalus | 9.20e-04 | 7 | 198 | 2 | C0549423 | |
| Disease | serum N-desmethylclozapine measurement | 1.22e-03 | 8 | 198 | 2 | EFO_0600043 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 1.22e-03 | 8 | 198 | 2 | EFO_0800533 | |
| Disease | Congenital Hydrocephalus | 1.22e-03 | 8 | 198 | 2 | C0020256 | |
| Disease | Acute erythroleukemia - M6a subtype | 1.22e-03 | 8 | 198 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 1.22e-03 | 8 | 198 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 1.22e-03 | 8 | 198 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 1.22e-03 | 8 | 198 | 2 | C2930974 | |
| Disease | Microphthalmia associated with colobomatous cyst | 1.22e-03 | 8 | 198 | 2 | C2931501 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 1.22e-03 | 8 | 198 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | Aqueductal Stenosis | 1.22e-03 | 8 | 198 | 2 | C2936786 | |
| Disease | Uterine Neoplasms | 1.56e-03 | 9 | 198 | 2 | C0042138 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.56e-03 | 9 | 198 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 1.56e-03 | 9 | 198 | 2 | EFO_0800034 | |
| Disease | Hydrocephalus | 1.56e-03 | 9 | 198 | 2 | C0020255 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 1.56e-03 | 9 | 198 | 2 | EFO_0800314 | |
| Disease | X-21467 measurement | 1.56e-03 | 9 | 198 | 2 | EFO_0020007 | |
| Disease | cholesteryl ester 16:0 measurement | 1.81e-03 | 36 | 198 | 3 | EFO_0010341 | |
| Disease | Disproportionate short stature | 1.82e-03 | 77 | 198 | 4 | C0878659 | |
| Disease | Uterine Cancer | 1.95e-03 | 10 | 198 | 2 | C0153567 | |
| Disease | citrate measurement | 2.00e-03 | 79 | 198 | 4 | EFO_0010114 | |
| Disease | platelet crit | NUP210L CYP21A2 ETS1 NCAPG2 LAPTM5 RCOR1 RBM27 FNTB DOCK10 PPARG CPS1 THADA CSTF1 DOT1L ENO1 | 2.02e-03 | 952 | 198 | 15 | EFO_0007985 |
| Disease | exploratory eye movement measurement | 2.19e-03 | 81 | 198 | 4 | EFO_0007700 | |
| Disease | Liver carcinoma | 2.36e-03 | 507 | 198 | 10 | C2239176 | |
| Disease | glutamine measurement, amino acid measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0005134, EFO_0009768 | |
| Disease | 3-methylglutarylcarnitine (2) measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0800074 | |
| Disease | plasma N-desmethylclozapine measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0600039 | |
| Disease | Giant Cell Glioblastoma | 2.50e-03 | 84 | 198 | 4 | C0334588 | |
| Disease | Malignant neoplasm of breast | MAOA TRMT11 DYSF HOXB9 CLCN1 FLNA RB1 DYNC2H1 SYNE1 DTX3 MTMR8 CPT1A MSH6 CHD5 DIP2C ENO1 | 2.52e-03 | 1074 | 198 | 16 | C0006142 |
| Disease | breakfast skipping measurement | 2.83e-03 | 12 | 198 | 2 | EFO_0010129 | |
| Disease | uric acid measurement | CYP21A2 TENM2 FANCA PLEKHH1 FLRT1 DYNC2H1 PPARG CPS1 REEP3 NSUN3 DIP2C | 2.90e-03 | 610 | 198 | 11 | EFO_0004761 |
| Disease | stromal cell-derived factor 1 alpha measurement | 3.01e-03 | 43 | 198 | 3 | EFO_0008293 | |
| Disease | serum non-albumin protein measurement | 3.17e-03 | 361 | 198 | 8 | EFO_0004568 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.33e-03 | 13 | 198 | 2 | C1846647 | |
| Disease | pallidum volume change measurement | 3.33e-03 | 13 | 198 | 2 | EFO_0021494 | |
| Disease | glutaroyl carnitine measurement | 3.33e-03 | 13 | 198 | 2 | EFO_0021005 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.43e-03 | 45 | 198 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | serum gamma-glutamyl transferase measurement | CLUAP1 NUP210L CYP21A2 ZNF804A TENM2 RCOR1 UGT2B15 FLRT1 ICE2 UGT1A6 PIK3R3 PPARG CPS1 THADA | 3.63e-03 | 914 | 198 | 14 | EFO_0004532 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.63e-03 | 291 | 198 | 7 | EFO_0008317, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNIPSLDSIKNYYRK | 146 | Q0P6H9 | |
| LYYKGLSKTLLTFKF | 666 | Q8NHY2 | |
| LKELGTKYKYSLLTD | 216 | Q8IV48 | |
| PSKFKDTYLVYILNE | 246 | Q9H0S4 | |
| PLSKAEYLKRYLSGA | 6 | Q9BRD0 | |
| ARAVGKPYLLALKTY | 531 | Q8NCV1 | |
| KPYLLALKTYEAAKA | 536 | Q8NCV1 | |
| AFSDRKLKPLIYVYS | 81 | Q8NDM7 | |
| DKTVKYSNLPNYLLG | 966 | Q8NDM7 | |
| SLHYLKLSDPKYLRE | 106 | Q6UX73 | |
| YKIDYKLLLTGTPLQ | 866 | Q8TDI0 | |
| LSVEAKRYKIYPLAL | 2071 | Q68DQ2 | |
| YLKKTPEEAYRALLS | 106 | Q9UNH5 | |
| ATLYAAKKYIVPALA | 211 | Q96KE9 | |
| AIPYKRKYLSDNHIL | 156 | Q8IX05 | |
| TNLKPATIKVYDYYL | 1426 | A8K2U0 | |
| KILKELTSNYIPSYL | 1236 | Q9HAR2 | |
| IHQALRYKELKLPSY | 16 | Q5T5M9 | |
| YVVSKYLAVESPFLK | 661 | P50416 | |
| VLYYVSLRFIKQKPS | 656 | Q9H221 | |
| SKDLDYYGTLLKKLA | 271 | Q10567 | |
| SEYLAPLSAVDLKLY | 76 | P20594 | |
| YTKTPQYKASLQELL | 501 | Q8TEK3 | |
| KDYQYPKSLDILSNV | 426 | Q96K78 | |
| RLKTLDTKPGLYTAY | 371 | Q8NEG7 | |
| LPNYTELKGKTALQY | 566 | Q6DHV5 | |
| ILASKSYYDILGVPK | 21 | Q9UBS3 | |
| VTLPNKSFYEKLYNR | 946 | Q96BY7 | |
| LKYPELYKTSQNALD | 921 | Q9Y2Q0 | |
| SYKSLYGKDLIADLK | 61 | P08133 | |
| LLKKSPVLQYLYYLA | 611 | Q01432 | |
| VLSSLFLKLYRKPTY | 1401 | Q04656 | |
| PLKSTSLSLFYKKVY | 641 | P06400 | |
| LPDKSIASLVKFYYS | 221 | Q9UKL0 | |
| DKLFESLYTKNYLPL | 66 | Q9P2N5 | |
| SPVKSYDYLLKFLLV | 6 | Q96S21 | |
| YTKALLAYAFSLLGK | 1151 | P20742 | |
| SYPRFLKSDIYLNLL | 186 | Q08116 | |
| YGLSYSVISYLKKLS | 446 | Q9UL03 | |
| LAKLEKYYLKNSPDL | 1041 | Q8TB72 | |
| LLLQDYSVKKSYPFR | 296 | Q6NSI4 | |
| DKYPKDILTYTELVL | 1736 | O00763 | |
| VTALGFVLYKYKLLP | 511 | P21397 | |
| YSYIIKTILKFPSAQ | 216 | A6NIJ9 | |
| KSFDKNLYRQLISYP | 216 | P33991 | |
| ELTSKKSLQVPSIYY | 96 | Q9UM21 | |
| QYKKLLGYVSLSPAL | 96 | Q9BQT8 | |
| LYRKYLELSKNGTEP | 1146 | Q504Q3 | |
| KKYYLLNAASLLPVL | 111 | Q9H649 | |
| YSPETKKLISLAYTL | 266 | P58181 | |
| YLKIIRAIYDKPTAN | 626 | O00370 | |
| TLPDFKLYYKATVTK | 871 | O00370 | |
| KKLDSPGYAAETYLK | 816 | Q9HBG6 | |
| KLDPSEVYLKSKTLY | 701 | Q5TCQ9 | |
| YTNDSIFLKKTLYIP | 71 | Q96S90 | |
| LARYKGLNLTEDTYK | 391 | Q08380 | |
| LILKDKLTYDSYSPD | 606 | Q16706 | |
| LLEDQKKYLNPLYSS | 461 | Q9Y217 | |
| DRYVSKKPANGILYL | 16 | Q96EF0 | |
| LQDSKYYITLTIPLA | 516 | Q15034 | |
| TYKLVSKNYPDLSLG | 96 | P08686 | |
| LLSLKYENDYPSVIL | 196 | P14921 | |
| YALAPVATVKYTKSL | 196 | P07098 | |
| TNKLLYAKDIPTYKE | 1466 | O60486 | |
| PKYKSSLLNRYLNDS | 216 | Q8IYA7 | |
| LAYLPFKLEKSIDSY | 391 | Q9Y5H3 | |
| SKVYTRTPTLYLDFK | 161 | O00625 | |
| TFLYEKLYTGKPNLV | 31 | Q9UKR5 | |
| PAILDLIIKYLYSAS | 81 | O60662 | |
| YTPLDEKSLALLLGY | 241 | Q15014 | |
| PYTKYQTLELEKEFL | 291 | P28356 | |
| LKRYASLLKYAGEPV | 1356 | P42704 | |
| LTPDEYLTYSLKLKK | 196 | P32455 | |
| KLLSKYVPVANRYEG | 156 | Q9BRR3 | |
| TISYASEKYEPVLLK | 1261 | P23471 | |
| PSENYSKYLLSLKEK | 531 | P52701 | |
| KALEEPKYSSLYAQL | 121 | P78344 | |
| KLGLDYSYDLAPRAK | 421 | Q6P4A8 | |
| KDAVYNSPKVYLLIG | 166 | Q6UWY5 | |
| SSPNGIIKKYTIYLK | 826 | Q9UMZ3 | |
| NLEKYTDYILKITPS | 1156 | Q9UMZ3 | |
| VDKLPLYASVSLYLL | 111 | A8MVW0 | |
| PYTKYQTLELEKEFL | 191 | P17482 | |
| SYALILYSVLKLNSP | 226 | Q8NGI1 | |
| YASLGTALYGKEKPL | 301 | Q460N5 | |
| KLDTRLLYPVSKYQQ | 416 | O00459 | |
| EYLGVTSFKRKYPDL | 96 | Q8WUB8 | |
| AEPYNLYSSLKELVL | 416 | Q92569 | |
| YTSKPKEKLVYAIFL | 386 | Q9BTY2 | |
| PYYLVKESLKAGISI | 276 | Q8NCM8 | |
| RCLLQSLKDSPYYKG | 1306 | Q8NCM8 | |
| VSKDATLLLPSYEKY | 221 | Q8N9I9 | |
| TADSLRYIYPKLKTD | 86 | Q9NR50 | |
| LADLYKSFIKDYPVV | 276 | P06733 | |
| IKVSGLLVLDYSKDY | 126 | P31327 | |
| PLYLSTKNTILKKYD | 206 | O75874 | |
| RKLKGYDSYNTLLLP | 1876 | Q4G0P3 | |
| RSYVDLLVKYAKIPA | 106 | Q659A1 | |
| YIYKEPKLTGLSEIS | 1896 | Q96BY6 | |
| YSLAKSYASTPELRK | 1601 | Q9BZ29 | |
| LTTVAYKLGREKPAY | 301 | Q14410 | |
| SSFEKYPLYVLKVSG | 151 | Q96IY4 | |
| TGSSILPALDNKKYY | 331 | Q00532 | |
| SRLYSVSYLLKDKGE | 2611 | P21333 | |
| GKYRSLLTDYISLAK | 501 | O15360 | |
| TLYTAKKYAVPALEA | 151 | Q9H0C5 | |
| GYKLSPEDYTLKVSQ | 346 | P07339 | |
| KPTASAIEKDILRYY | 151 | Q8WXX0 | |
| KANSLYVIKLSEPDY | 3006 | Q8WXX0 | |
| GTEFKSIYSLDKLYP | 36 | Q14197 | |
| DTNGKPLYILTYGKL | 341 | Q9Y2E4 | |
| KSLPLVRKIAAEYYD | 271 | O15121 | |
| IDVTKSYYQKFLPLT | 166 | Q9BTE1 | |
| IKVKPSFLEYLSYLL | 176 | Q6ZNC8 | |
| TLLRPSDKVSNYYKT | 686 | Q8N7U6 | |
| KLLQYLYSLKQPDGS | 176 | P49356 | |
| KIVSYLLVAEPDKLY | 211 | O95718 | |
| KTEYLLTALEPKSTY | 461 | Q9NZU1 | |
| LGELSLIDADPYLKY | 336 | P20248 | |
| GSRDYTLKLFDYSKP | 191 | Q05048 | |
| KFPSLNKLVDYYRTN | 121 | O75791 | |
| YVTPTKYLELLSGYK | 2976 | Q9P225 | |
| IPKDGSLASYKEYIS | 4086 | Q9P225 | |
| ILKSLPCYKSISGRY | 3406 | Q9NZJ4 | |
| TLPLEKDLKITLYDY | 1636 | O75923 | |
| KVPYKLGLSLTIIAY | 126 | Q6P995 | |
| IYKKPVRTDLNYIAA | 4586 | Q8TE73 | |
| NLKYYVSPSDLLDDK | 221 | Q15648 | |
| SKIRILKYSEAEYAP | 186 | Q5VU65 | |
| LLSPYTKGASLLYRK | 76 | Q9H6H4 | |
| FYSLVYDPSLKTLLA | 131 | Q9BTC8 | |
| PYVDGLSKLAVTSYK | 181 | Q9NQT8 | |
| QRTDAYVKSYLLPDK | 441 | Q8TDW5 | |
| KLSYKQLPFLLYQVT | 171 | Q7L3T8 | |
| KYYLDVLVSDASKPS | 281 | Q7Z4G4 | |
| QKSYVIDYYLPKLLS | 541 | Q6YHU6 | |
| IFSLVKYVPLTYNKT | 521 | P31641 | |
| LARKYGYILPDITKD | 236 | Q9P015 | |
| SKTLPAAYIKAYLLE | 146 | Q9H426 | |
| QKEKYLGLYTILPSE | 5381 | Q8NF91 | |
| GEKYQLYLSSLKETL | 951 | Q969F9 | |
| LGSYIELPAYLKLAS | 111 | Q13571 | |
| KSSLLKKYLLDGISY | 156 | A6NDU8 | |
| GSKSLPATYIKVYLL | 186 | Q9UJD0 | |
| ALYAFLSPSPDYLKV | 616 | Q9H3E2 | |
| KVGLKTVLSYLYVNP | 246 | Q9UPU3 | |
| LYDSYIKSFPLTKAK | 246 | P37231 | |
| LPALIFAVKLAKYYR | 806 | O43490 | |
| IYTLGPTYLDDNVKK | 281 | Q9H2Y9 | |
| SPKKLYLTGNYLQTV | 376 | Q9H156 | |
| LGYLSKAKDIYNSIL | 681 | Q5VXU9 | |
| LLKYRPEFLKSYDAA | 161 | Q9UHJ6 | |
| LKTLSQGSYLYLKLT | 646 | Q9HCD6 | |
| LSFLYDKKYLPHLAV | 676 | Q8TF17 | |
| YLSSRTAGYKSLLKI | 1071 | Q9NT68 | |
| AILYTYKLSKGLTEE | 826 | O15457 | |
| LLSPYTKGSSLLYRK | 76 | Q9H902 | |
| TRLVLDPYLLKYFNK | 31 | Q9Y2R5 | |
| GLUSYSLRYILLKKS | 271 | P59797 | |
| KVSLPLRTNYLYGKI | 226 | P47972 | |
| AVVLNSKDKAPYLIY | 386 | Q9UBF8 | |
| LQSASVSKKYLPFYL | 711 | Q9NZP6 | |
| PLIYSLRNKDVKYAL | 286 | Q8NH51 | |
| LLSPYTKGASLIYRK | 76 | Q6NUK4 | |
| QVPKIYKYYSLLASL | 196 | Q9BX79 | |
| YAPKGSSLVLYSDKK | 356 | O95470 | |
| LLKNPKIADYLTRYE | 261 | Q8TCG1 | |
| KKSDSRNYLPILNSY | 146 | Q9C0C6 | |
| YTINKFASVLPEYLK | 646 | Q86XI2 | |
| SLYDSIIQVKKLPYL | 576 | P35523 | |
| SLYDSIIRIKKLPYL | 551 | P51788 | |
| LEPSYQKSLQTYLKS | 296 | O75122 | |
| GYAVKELLKITSVLY | 91 | Q96AJ1 | |
| AGIKCLLTYKPDVYT | 236 | Q9H3H3 | |
| RYLTSGLKVYYLPLK | 81 | P37287 | |
| LYYIGKTPKIEQLSN | 391 | P61812 | |
| YYKPLKATALQKFLA | 61 | Q96PP4 | |
| KTYLLGTDLSIFKYD | 396 | Q96JG6 | |
| NLLYYSKLGLVIPSS | 306 | Q9ULJ3 | |
| YKNLVYLPTAFLLSS | 341 | Q8IUH4 | |
| YRLFPKALGQLISKY | 66 | Q969N2 | |
| YSLLIDTYIKDPKER | 176 | P31350 | |
| PTLKAYAEALKENSY | 211 | P28289 | |
| LKGTILYLQKDEYRP | 546 | Q9BQI7 | |
| SSIKPLEQSYKYNEL | 66 | Q86TD4 | |
| ILSSPYFKVQLYELK | 66 | Q5VTL8 | |
| TTENLYKKYVFLDPL | 191 | A8MWX3 | |
| LAGLPEYLSKTSKYL | 91 | Q9Y5S1 | |
| DLKLSYLSSRAAGYK | 1001 | Q9P273 | |
| KYISNPLLIGRYKCD | 241 | Q9BWV7 | |
| RLIYPSLNSEKYEKF | 446 | Q8N841 | |
| EKKTYYLTADSPSLL | 646 | Q9ULM0 | |
| PALATYYGSLFKLTD | 71 | Q8IUF8 | |
| VKLLDYTEKPLYENL | 306 | Q99986 | |
| LTNKYVLSVLKFTYP | 21 | Q24JQ0 | |
| PYEVSKKLYTLKQSL | 236 | Q99598 | |
| YLIALKSSGLTYPED | 296 | Q6ZT12 | |
| KSIGLYLRSQKIPLY | 1411 | Q86YA3 | |
| AIKLEVYPTSLTKNY | 71 | P54855 | |
| YATEKLKSLGYLCGL | 391 | P48553 | |
| PEVNLLLKESKYYTR | 61 | P19224 | |
| VLLTYLPKNYAKSEL | 116 | Q8TB96 | |
| QKIYDLSDSKIYLVP | 606 | Q8IWB9 | |
| LLPYSNYRNKLTDEK | 566 | Q96PF1 | |
| YIKSSKISRLPAYLT | 311 | P54578 | |
| PELRYLSLAYNKIAK | 371 | Q6P2D8 | |
| YQLEALKSKYVLLNP | 51 | Q9P275 | |
| LAEYLIKPLNKTYLE | 501 | O94874 | |
| KDLLYVIAYGPSQVK | 256 | Q9P2D8 | |
| GKYLLEPISEKQYLA | 631 | Q7Z570 | |
| YLTPYRVIFLSKGKD | 51 | Q969T9 | |
| LLAYGAKAELPKYKS | 206 | Q9NP98 |